Molecure Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Marcin Szumowski

Chief executive officer

zł548.0k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.7%
Management average tenure3.3yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO

Marcin Szumowski

no data

Tenure

zł548,043

Compensation

Mr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...


Leadership Team

NamePositionTenureCompensationOwnership
Marcin Szumowski
Co-Founderno datazł548.04k0.70%
PLN 1.7m
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.3yrszł500.00k3.01%
PLN 7.5m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł414.20k0.20%
PLN 512.8k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.3yrszł376.64k0.11%
PLN 280.7k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.3yrszł345.44k0.034%
PLN 86.2k
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno datano datano data
Samson Fung
Chief Medical Officer & Member of Management Board1.3yrsno datano data
Magdalena Tyszkiewicz
Head of CMC4.3yrsno datano data
Marta Borkowska
Director of the Management Board Office2.3yrsno datano data

3.3yrs

Average Tenure

Experienced Management: MOC's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Reynold A. Panettieri
Member of Scientific Advisory Boardno datano datano data
Bart Lambrecht
Member of Scientific Advisory Boardno datano datano data
Jakub Golab
Member of Scientific Advisory Boardno datano datano data
Tomasz Piec
Vice Chairman of the Supervisory Board4.3yrszł140.98kno data
Douglas Hay
Member of Scientific Advisory Boardno datano datano data
Rafal Kaminski
Member of the Supervisory Board2.3yrszł63.46kno data
Paul Van Der Horst
Member of Supervisory Board2.3yrszł117.62k0.059%
PLN 148.6k
Mariusz Gromek
Member of Supervisory Boardno datazł112.78kno data
Piotr Zólkiewicz
Independent Chairman of Supervisory Board3.3yrszł197.37kno data
Rafal Krenke
Member of Scientific Advisory Boardno datano datano data
Bruce Conway
Member of Scientific Advisory Boardno datano datano data
Nancy Van Osselaer
Member of the Supervisory Board & Member of Scientific Advisory Board2.5yrszł117.62kno data

2.5yrs

Average Tenure

Experienced Board: MOC's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.